Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Emerg Med Australas ; 31(6): 961-966, 2019 12.
Artigo em Inglês | MEDLINE | ID: mdl-30927341

RESUMO

OBJECTIVE: The present study aims to describe the characteristics of early ED re-presentations in a regional hospital in New South Wales, Australia. METHODS: This was a retrospective review of all patients re-presenting within 72 h of discharge from Coffs Harbour Base Hospital ED, a regional ED, for the 2016-2017 financial year. Presentations were categorised according to their diagnosis and cause for re-presentation. RESULTS: Of the 38 986 presentations to the ED within the study period, 2125 patients met re-presentation inclusion criteria (5.45%). Diagnoses most likely to re-present were injury/trauma (18.8%), gastrointestinal (14.8%) and psychiatric (12.5%). The most common cause for re-presentation was disease progression (32.7%). Patients aged over 66 were the most likely to be admitted on re-presentation (35.8%) followed by the 17-65 age group (24.2%) and the <16 age group (18.7%). CONCLUSIONS: Re-presentations were common, but did not lead to increased admissions. The regional hospital in the present study had a higher 72 h ED re-presentation rate than the comparative major city hospital. In particular, paediatric and psychiatric re-presentations were a greater burden to the regional ED. This may be secondary to a lack of alternative services, particularly for these patient groups. Improving these outpatient services may help to reduce the burden of 72 h ED re-presentations.


Assuntos
Serviço Hospitalar de Emergência/estatística & dados numéricos , Readmissão do Paciente/estatística & dados numéricos , Adolescente , Adulto , Idoso , Progressão da Doença , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , New South Wales , Estudos Retrospectivos
2.
Emerg Med Australas ; 28(6): 654-657, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27701829

RESUMO

BACKGROUND: Multiple cardiac and non-cardiac processes may cause an elevated highly sensitive troponin (hsTn). We postulated that the consumption of a seriously hot vindaloo could cause an increase in hsTn levels in seemingly healthy volunteers. OBJECTIVE: To determine whether eating a very hot curry can cause elevated hsTn. METHODS: This was a prospective observational cohort study. Participants had blood drawn for hsTn pre-ingestion and at 2 and 4 h post-ingestion of, first, a rather mild butter chicken and, 2 weeks later, a seriously hot lamb vindaloo. We assessed pre-curry tolerance and perception of curry hotness for both curries using the VHOT scale. RESULTS: Although no participant had a troponin above the reference range at any point in time, we found dramatic relative increases in troponin in many of our participants. In the vindaloo phase, 8/22 (36%) had a relative change >20%, whereas 5/22 (23%) had a relative change >50% at 4 h. However, these changes were not significantly different to those in the butter chicken phase. Based on biological variability alone, 15/22 (68%) had a relative change of >20%, and 11/22 (50%) had a relative change of >50% between the two sessions (pre-ingestion). CONCLUSIONS: Eating a seriously hot vindaloo does not appear to be a risk factor for troponitis, and people may consume vindaloo safely with the knowledge that this is unlikely to result in significant damage to their myocardium. However, clinicians should be aware of the biological variability of hsTn and exercise caution when interpreting apparent changes within the normal range.


Assuntos
Capsicum/efeitos adversos , Aditivos Alimentares/efeitos adversos , Especiarias/efeitos adversos , Troponina I/sangue , Adulto , Biomarcadores/sangue , Feminino , Humanos , Masculino , Estudos Prospectivos , Valores de Referência
3.
Emerg Med Australas ; 23(6): 689-96, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22151667

RESUMO

OBJECTIVE: The percentage of mental health (MH) presentations to New South Wales (NSW) EDs in recent years has not been described at the statewide level. Evidence from other states suggests this burden might be increasing. The present study aims to evaluate recent trends in MH presentations to NSW EDs, including geographic variations and the spectrum of MH disorders encountered. METHODS: Data were sourced from the NSW Emergency Department Data Collection, which collates information from routine reporting undertaken in all NSW EDs. The database employs ICD-9 diagnostic descriptors. The present study retrospectively analyses presentations from 1999 to 2006 for patients who received an MH primary discharge diagnosis, as defined by ICD-9. In addition, rates of presentation for poisoning are considered. The percentage of MH presentations to the three largest hospital categories--principal referral, major metropolitan and rural base (i.e. major non-metropolitan)--is examined. RESULTS: During 1999 and 2006, there were 9,013,357 ED presentations at the study sites. Of these, 3.22% received an MH primary discharge diagnosis. An additional 0.93% received a diagnosis of poisoning. In 2006, there were 15,262 more MH presentations than in 1999, a 49.78% increase. Over this period, total annual ED presentations increased by 201,763 (19.30%). General population growth was 6.31%. Across the state, 32.0% of MH presentations were for psychotic conditions and 68.0% for neurotic illnesses. CONCLUSION: Mental health presentations to NSW EDs are increasing. There is a need to review emergency services to accommodate these changes. The reasons for this growth remain unclear and require formal prospective evaluation.


Assuntos
Serviço Hospitalar de Emergência/estatística & dados numéricos , Hospitais Públicos/estatística & dados numéricos , Transtornos Mentais/epidemiologia , Hospitais Rurais/estatística & dados numéricos , Hospitais Urbanos/estatística & dados numéricos , Humanos , Estudos Longitudinais , New South Wales/epidemiologia , Intoxicação/epidemiologia , Estudos Retrospectivos
5.
Med J Aust ; 182(8): 407-11, 2005 Apr 18.
Artigo em Inglês | MEDLINE | ID: mdl-15850438

RESUMO

OBJECTIVE: To investigate species-specific envenoming rates and spectrum of severity of funnel-web spider bites, and the efficacy and adverse effects of funnel-web spider antivenom. DATA SOURCES: Cases were identified from a prospective study of spider bite presenting to four major hospitals and three state poisons information centres (1999-2003); museum records of spider specimens since 1926; NSW Poisons Information Centre database; MEDLINE and EMBASE search; clinical toxinology textbooks; the media; and the manufacturer's reports of antivenom use. DATA EXTRACTION: Patient age and sex, geographical location, month, expert identification of the spider, clinical effects and management; envenoming was classified as severe, mild-moderate or minor/local effects. DATA SYNTHESIS: 198 potential funnel-web spider bites were identified: 138 were definite (spider expertly identified to species or genus), and 77 produced severe envenoming. All species-identified severe cases were attributed to one of six species restricted to NSW and southern Queensland. Rates of severe envenoming were: Hadronyche cerberea (75%), H. formidabilis (63%), Atrax robustus (17%), Hadronyche sp. 14 (17%), H. infensa (14%) and H. versuta (11%). Antivenom was used in 75 patients, including 22 children (median dose, 3 ampoules; range, 1-17), with a complete response in 97% of expertly identified cases. Three adverse reactions were reported, all in adults: two early allergic reactions (one mild and one with severe systemic effects requiring adrenaline), and one case of serum sickness. CONCLUSIONS: Severe funnel-web spider envenoming is confined to NSW and southern Queensland; tree-dwelling funnel webs (H. cerberea and H. formidabilis) have the highest envenoming rates. Funnel-web spider antivenom appears effective and safe; severe allergic reactions are uncommon.


Assuntos
Antivenenos/administração & dosagem , Poliaminas/toxicidade , Picada de Aranha/epidemiologia , Adulto , Animais , Antivenenos/efeitos adversos , Criança , Estudos Transversais , Inquéritos Epidemiológicos , Humanos , New South Wales/epidemiologia , Northern Territory/epidemiologia , Poliaminas/antagonistas & inibidores , Estudos Prospectivos , Queensland/epidemiologia , Especificidade da Espécie , Picada de Aranha/diagnóstico , Picada de Aranha/tratamento farmacológico , Austrália Ocidental/epidemiologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA